Antinociceptive effects of intracerebroventricular injection of the galanin receptor 1 agonist M 617 in rats

Neuroscience Letters

Volumn 491, Issue 3, 2011, Pages 174-176

  Fu, Li Bo ^a,b   Wang, Xue Bin ^a,c   Jiao, Shi ^a,d   Wu, Xia ^a   Yu, Long Chuan ^a  

^a PEKING UNIVERSITY   (China)

^b CHANGCHUN NORMAL UNIVERSITY   (China)

^c LINYI UNIVERSITY   (China)

^d SHENYANG AGRICULTURAL UNIVERSITY   (China)

Author keywords

Antinociceptive effect; Galanin; Galanin receptor 1; Hindpaw withdrawal latency; Intracerebroventricular injection; M 617

Indexed keywords

GALANIN; GALANIN DERIVATIVE; GALANIN RECEPTOR 1; GALANIN RECEPTOR 1 AGONIST; M 617; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY;

ANALGESICS; ANIMALS; BRADYKININ; GALANIN; INJECTIONS, INTRAVENTRICULAR; MALE; PEPTIDE FRAGMENTS; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, GALANIN, TYPE 1;

EID: 79951770798     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.01.030     Document Type: Article

References (18)

1. Cheng Y., Yu L.-C. Galanin protects against Aβ-induced neurotoxicity on hippocampal neurons in rats. J. Alzheimer's Dis. 2010, 20:1143-1157.
2. Gu X.L., Sun Y.G., Yu L.-C. Involvement of galanin in nociceptive regulation in the arcuate nucleus of hypothalamus in rats with mononeuropathy. Behav. Brain Res. 2007, 179:331-335.
3. Hua X., Hayes C., Hofer A., Fitzsimmons B., Kilk K., Langel U., Bartfai T., Yaksh T. Galanin acts at GalR1 receptors in spinal antinociception: synergy with morphine and AP-5. J. Pharmacol. Exp. Ther. 2004, 308:574-582.
4. Jimenez-Andrade J.M., Lundström L., Sollenberg U.E., Langel U., Castañeda-Hernandez G., Carlton S.M. Activation of peripheral galanin receptors: differential effects on nociception. Pharmacol. Biochem. Behav. 2006, 85:273-280.
5. Jin W., Liu Z., Liu D., Yu L.-C. Antinociceptive effects of galanin in the central nucleus of amygdala of rats, an involvement of opioid receptors. Brain Res. 2010, 1320:16-21.
6. Lang R, Gundlach A., Kofler B. The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol. Ther. 2007, 115:177-207.
7. Liu H., Hokfelt T. The participation of galanin in pain processing at the spinal level. Trends Pharmacol. Sci. 2002, 23:468-474.
8. Lundstrom L., Sollenberg U., Brewer A., Kouya P., Zheng K., Xu X., Sheng X., Robinson J., Wiesenfeld-Hallin Z., Xu Z., Hokfelt T., Bartfai T., Langel U. A galanin receptor subtype 1 specific agonist. Int. J. Pept. Res. Ther. 2005, 11:17-27.
9. Mitsukawa K., Lu X., Bartfai T. Galanin, galanin receptors and drug targets. Cell. Mol. Life Sci. 2008, 65:1796-1805.
10. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Cademic Press, Sydney. fourth ed.
11. Sollenberg U.E., Runesson J., Sillard R., Langel Ü. Binding of chimeric peptides M617 and M871 to galanin receptor type 3 reveals characteristics of galanin receptor-ligand interaction. Int. J. Pept. Res. Ther. 2010, 16:17-22.
12. Sun Y., Gu X., Lundeberg T., Yu L.-C. An antinociceptive role of galanin in the arcuate nucleus of hypothalamus in intact rats and rats with inflammation. Pain 2003, 106:143-150.
13. Wang D., Ye H., Yu L.-C., Lundeberg T. Intra-periaqueductal grey injection of galanin increases the nociceptive response latency in rats, an effect reversed by naloxone. Brain Res. 1999, 834:152-154.
14. Wang D., Lundeberg T., Yu L.-C. Antinociceptive role of galanin in periaqueductal grey of rats with experimentally induced mononeuropathy. Neuroscience 2000, 96:767-771.
15. Xiong W., Gao L., Sapra A., Yu L.-C. Antinociceptive role of galanin in the spinal cord of rats with inflammation, an involvement of opioid system. Regul. Pept. 2005, 132:85-90.
16. Wu X., Yu L.-C. Alternation of galanin in nociceptive modulation in the central nervous system of rats during morphine tolerance: a behavioral and immunohistochemical study. Brain Res. 2006, 1086:85-91.
17. Xu W., Lundeberg T., Wang Y., Li Y., Yu L.-C. Antinociceptive effect of calcitonin gene-related peptide in the central nucleus of amygdala: activating opioid receptors through amygdala-periaqueductal gray pathway. Neuroscience 2003, 118:1015-1022.
18. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.